• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There aren't many studies on how long-term exposure may affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should evaluate the benefits of using it versus the dangers for the baby. Physicians don't have the data needed to make unequivocal recommendations but they can provide information regarding the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based study of case control to assess the frequency of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to ensure that the classification was correct and to eliminate any bias.

The study of the researchers was not without limitations. most common adhd medications important, they were unable to separate the effects of the medication from the underlying disorder. This limitation makes it difficult for researchers to determine if the small associations observed among the exposed groups were due to medication use or caused by the presence of comorbidities. Additionally the researchers did not examine long-term offspring outcomes.

The study revealed that infants whose mother took ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy or stopped taking their medication before or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risk of using ADHD medications in early pregnancies can be offset by greater benefits to both mother and baby of continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve coping skills which can reduce the impact of her disorder on her daily functioning and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to keep treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of solid and reliable evidence either way, so physicians must weigh their knowledge, the experiences of other doctors, and what the research suggests on the subject as well as their own best judgment for each patient.

The issue of risk to the infant can be particularly tricky. The research on this issue is based on observation rather than controlled studies and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which may undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study presented in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion A few studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even slightly negative, impact. In the end, a careful risk/benefit analysis must be done in each case.

For many women with ADHD, the decision to discontinue medication is difficult, if not impossible. In fact, in a recent article in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. Furthermore, a loss of medication may affect the ability to do job-related tasks and drive safely that are crucial aspects of a normal life for a lot of people with ADHD.

She recommends that women who are unsure about whether or not to discontinue medication due to their pregnancy should consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment regimen. In addition, educating them can make the woman feel more comfortable when she is struggling with her decision. It is also worth noting that certain medications can be absorbed through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be passed on to the baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these drugs might have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers utilized two massive datasets to analyze more than 4.3 million pregnancies and determine whether stimulant medications caused birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.

The researchers of the study found no link between early medication use and congenital abnormalities like facial clefting, or club foot. The results are in agreement with previous studies that showed an insignificant, but small increase in cardiac malformations for women who began taking ADHD medication prior to the time of the time of pregnancy. The risk grew during the latter part of pregnancy, when many women begin to discontinue their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean, have a low Apgar after birth and have a baby that needed help breathing when they were born. However, the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their study will inform physicians when they see pregnant women. They suggest that although the discussion types of adhd Medication the risks and benefits is crucial but the decision to stop or maintain medication should be based on each woman's requirements and the severity of her adhd medication adderall uk symptoms.

The authors warn that, while stopping the medication is a possibility to think about, it isn't recommended due to the high rate depression and mental health issues in women who are expecting or who have recently given birth. Further, research shows that women who stop taking their medication will have a harder adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mother can be overwhelming. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments, prepare for the birth of their child and adjust to a new routine. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medicines are absorbed by breast milk in very small amounts, therefore the risk to breastfeeding infant is minimal. The amount of exposure to medications will vary based on the dosage and frequency of administration as well as time of day. Additionally, different medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not yet fully understood.

Due to the absence of evidence, some doctors might be tempted to stop taking stimulant drugs during the pregnancy of a woman. This is a difficult choice for the patient, who must weigh the benefits of continuing her medication with the potential risks to the embryo. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have a history of ADHD or if they plan to take medication during the perinatal stage.

A increasing number of studies have shown that women can continue to take their ADHD medication while they are pregnant and nursing. In response, a rising number of patients are choosing to do this. They have found through consultation with their physicians, that the benefits of retaining their current medication outweigh any potential risks.

It is essential for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also be informed about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary effort including obstetricians, GPs, and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother and child, monitoring of signs of deterioration and, if necessary, adjustments to the medication regimen.